Monday, December 23

Tag: Columns

The Medicare Gold Rush Is Slowing Down
6Dec By adminNo Comments
Money

The Medicare Gold Rush Is Slowing Down

The popularity of private Medicare plans has been a huge driver of profits for insurance companies in recent years. There are signs the gold rush isn’t quite what it once was.Investors have been worried all year as the Biden administration phases in a new system that insurers say will reduce federal payments to Medicare Advantage plans. Developments last week at the top two insurers in the Medicare business, UnitedHealth Group and Humana, raised more questions. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
American Oil—Good to the Last Drop?
27Nov By adminNo Comments
Money

American Oil—Good to the Last Drop?

How low can they go?U.S. shale developers have been on a relentless chase to drill for oil as cheaply as possible. With plenty of cash in their pockets and a hunch that they might soon exhaust their best inventory in the prolific Permian Basin, some companies have been shifting their focus to making sure they get every last drop of crude they can get out of what they have. That could mean higher costs today.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Gene Editing Will Change Medicine—and Maybe Health Investing Too
24Nov By adminNo Comments
Money

Gene Editing Will Change Medicine—and Maybe Health Investing Too

It usually takes time for scientific discoveries in the lab to make their way to the market.The groundbreaking gene-editing technology known as Crispr, which acts like a molecular pair of scissors that can be used to cut and modify a DNA sequence, has moved rather quickly from the pages of scientific journals to the medical setting. Earlier this month, about three years after Jennifer Doudna and Emmanuelle Charpentier won the Nobel Prize in Chemistry for describing how bacteria’s immune system could be used as a tool to edit genes, regulators in the U.K. approved the first Crispr-based treatment for sickle cell disease and beta-thalassemia patients. The treatment, from Vertex Pharmaceuticals and Crispr Therapeutics, could be approved by the U.S. Food and Drug Administration early next mo...
Read More
OpenAI Glitch Shows Weaknesses in Microsoft’s AI Armor
20Nov By adminNo Comments
Money

OpenAI Glitch Shows Weaknesses in Microsoft’s AI Armor

Microsoft may have put out a five-alarm fire around its most important technology move in years. But fires leave scorch marks—and sometimes flare up again. A leadership crisis at Silicon Valley startup OpenAI over the weekend threatened to seriously singe the world’s second-largest company by market value. That is because OpenAI developed the key generative artificial-intelligence technology that has helped power Microsoft’s aggressive move into the field. Microsoft has invested a total of $13 billion into the company and already launched commercial products and services based on its technology, including a chatbot-enabled Bing search engine and a superpowered digital assistant called Copilot that can render emails, spreadsheets and PowerPoint presentations. Copyright ©2023 Dow Jones &...
Read More
OpenAI Glitch Shows Weaknesses in Microsoft’s AI Armor
20Nov By adminNo Comments
World

OpenAI Glitch Shows Weaknesses in Microsoft’s AI Armor

Microsoft may have put out a five-alarm fire around its most important technology move in years. But fires leave scorch marks—and sometimes flare up again. A leadership crisis at Silicon Valley startup OpenAI over the weekend threatened to seriously singe the world’s second-largest company by market value. That is because OpenAI developed the key generative artificial-intelligence technology that has helped power Microsoft’s aggressive move into the field. Microsoft has invested a total of $13 billion into the company and already launched commercial products and services based on its technology, including a chatbot-enabled Bing search engine and a superpowered digital assistant called Copilot that can render emails, spreadsheets and PowerPoint presentations. Copyright ©2023 Dow Jones &...
Read More
The Recorder – Connecting the Dots: Cutting IRS for the big money
13Nov By adminNo Comments
Money

The Recorder – Connecting the Dots: Cutting IRS for the big money

Give me money, that’s what I wantThe best things in life are freeBut you can keep ‘em for the bird and bees;Now give me money, (that’s what I want) yeahThat’s what I want.“Money (That’s What I Want)” is a rhythm and blues song which was the first hit record for Berry Gordy’s Motown Records in 1959. Many artists have recorded the tune, including the Beatles in 1963 and the Flying Liza­­­rds in 1979.The way today’s financial lizards get their money in America is “buy” the ability to shape government policy. And elections.Back in 2014, Martin Gilens and Benjamin I. Page published a study about political inequality in America called “Testing Theories of American Politics: Elites, Interest Groups, and Average Citizens.” Their central finding was this: Economic elites and interest groups can sh...
Read More
Warner Gets Too Real About Advertising Meltdown
9Nov By adminNo Comments
Money

Warner Gets Too Real About Advertising Meltdown

Even “Barbie” can only glam up her maker so much these days. Warner Bros. Discovery got a boost from the year’s biggest box-office hit during the third quarter. Its studio revenue grew 4% year over year, which is its first such gain in more than a year. But that was offset by continued weakness in advertising, which fell 12% year over year to just under $1.8 billion—a record low for the combined company’s reported results that go back to the beginning of 2021. Warner also lost about 1.4 million domestic subscribers to its streaming services that included the recently rebranded Max; analysts had been expecting a drop of only about 200,000 subscribers. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Robinhood No Longer Looks Like a Steal
8Nov By adminNo Comments
Money

Robinhood No Longer Looks Like a Steal

Robinhood Markets may be building the brokerage of the future—and maybe it always will be.Shares of the online brokerage are down nearly 15% after its third-quarter earnings report on Tuesday. One big factor: The revenue momentum from higher interest rates is petering out. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More